CR20140495A - 5-amino[1,4]thiazines como inhibidores de bace1 - Google Patents
5-amino[1,4]thiazines como inhibidores de bace1Info
- Publication number
- CR20140495A CR20140495A CR20140495A CR20140495A CR20140495A CR 20140495 A CR20140495 A CR 20140495A CR 20140495 A CR20140495 A CR 20140495A CR 20140495 A CR20140495 A CR 20140495A CR 20140495 A CR20140495 A CR 20140495A
- Authority
- CR
- Costa Rica
- Prior art keywords
- thiazines
- bace1
- inhibitors
- amino
- compound
- Prior art date
Links
- 102100021257 Beta-secretase 1 Human genes 0.000 title 1
- 101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000004897 thiazines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención proporciona un compuesto de fórmula I
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12169353 | 2012-05-24 | ||
| PCT/EP2013/060352 WO2013174781A1 (en) | 2012-05-24 | 2013-05-21 | 5-amino[1,4]thiazines as bace 1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20140495A true CR20140495A (es) | 2014-12-01 |
Family
ID=48534350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20140495A CR20140495A (es) | 2012-05-24 | 2014-10-27 | 5-amino[1,4]thiazines como inhibidores de bace1 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9273042B2 (es) |
| EP (1) | EP2855469B1 (es) |
| JP (1) | JP6251249B2 (es) |
| KR (1) | KR20150014934A (es) |
| CN (1) | CN104334554B (es) |
| AU (1) | AU2013265376B2 (es) |
| BR (1) | BR112014028813A2 (es) |
| CA (1) | CA2872179A1 (es) |
| CL (1) | CL2014003123A1 (es) |
| CO (1) | CO7131369A2 (es) |
| CR (1) | CR20140495A (es) |
| EA (1) | EA026004B1 (es) |
| IL (1) | IL235681A (es) |
| MA (1) | MA37691B1 (es) |
| MX (1) | MX2014013839A (es) |
| NZ (1) | NZ702254A (es) |
| PE (1) | PE20150021A1 (es) |
| PH (1) | PH12014502541A1 (es) |
| SG (1) | SG11201407575PA (es) |
| UA (1) | UA113438C2 (es) |
| WO (1) | WO2013174781A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014004181A2 (pt) * | 2011-08-22 | 2017-06-13 | Merck Sharp & Dohme | composto, composição farmacêutica, e, método de tratamento, prevenção, e / ou retardo do início de uma doença ou patologia |
| WO2014059185A1 (en) | 2012-10-12 | 2014-04-17 | Amgen Inc. | Amino - dihydrothiazine and amino - dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use |
| US9096615B2 (en) | 2013-07-30 | 2015-08-04 | Amgen Inc. | Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof |
| EP3043802B1 (en) | 2013-09-13 | 2018-04-18 | Merck Sharp & Dohme Corp. | C5-spiro iminothiazine dioxides as bace inhibitors, compositions, and their use |
| US9920072B2 (en) | 2014-11-03 | 2018-03-20 | Hoffmann-La Roche Inc. | BACE1 inhibitors |
| MX2017012188A (es) | 2015-03-20 | 2017-12-15 | Hoffmann La Roche | Inhibidores de beta-secretasa 1 (bace1). |
| US10246468B2 (en) | 2015-08-12 | 2019-04-02 | Hoffmann-La Roche Inc. | BACE1 inhibitors |
| JP7353708B2 (ja) | 2018-04-27 | 2023-10-02 | 塩野義製薬株式会社 | 選択的ｂａｃｅ１阻害活性を有するテトラヒドロピラノオキサジン誘導体 |
| CN110467611B (zh) * | 2018-05-11 | 2022-09-27 | 广东东阳光药业有限公司 | 亚氨基噻二嗪二氧化物衍生物及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006041404A1 (en) * | 2004-10-15 | 2006-04-20 | Astrazeneca Ab | Substituted amino-compounds and uses thereof |
| US8461160B2 (en) * | 2009-05-08 | 2013-06-11 | Hoffmann-La Roche, Inc. | Dihydropyrimidinones |
| US8188079B2 (en) | 2009-08-19 | 2012-05-29 | Hoffman-La Roche Inc. | 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines |
| US20110065695A1 (en) | 2009-09-11 | 2011-03-17 | Jeremy Beauchamp | Use of aminodihydrothiazines for the treatment or prevention of diabetes |
| UA103272C2 (uk) * | 2009-12-11 | 2013-09-25 | Ф. Хоффманн-Ля Рош Аг | 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2 |
| CA2832473A1 (en) * | 2011-04-13 | 2012-10-18 | Merck Sharp & Dohme Corp. | 5-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions, and their use |
| BR112014004181A2 (pt) * | 2011-08-22 | 2017-06-13 | Merck Sharp & Dohme | composto, composição farmacêutica, e, método de tratamento, prevenção, e / ou retardo do início de uma doença ou patologia |
-
2013
- 2013-05-21 US US14/400,448 patent/US9273042B2/en not_active Expired - Fee Related
- 2013-05-21 AU AU2013265376A patent/AU2013265376B2/en not_active Ceased
- 2013-05-21 KR KR1020147032555A patent/KR20150014934A/ko not_active Withdrawn
- 2013-05-21 CN CN201380026707.3A patent/CN104334554B/zh not_active Expired - Fee Related
- 2013-05-21 UA UAA201413535A patent/UA113438C2/uk unknown
- 2013-05-21 WO PCT/EP2013/060352 patent/WO2013174781A1/en not_active Ceased
- 2013-05-21 SG SG11201407575PA patent/SG11201407575PA/en unknown
- 2013-05-21 PE PE2014002013A patent/PE20150021A1/es not_active Application Discontinuation
- 2013-05-21 EA EA201492097A patent/EA026004B1/ru not_active IP Right Cessation
- 2013-05-21 JP JP2015513132A patent/JP6251249B2/ja not_active Expired - Fee Related
- 2013-05-21 NZ NZ702254A patent/NZ702254A/en not_active IP Right Cessation
- 2013-05-21 BR BR112014028813A patent/BR112014028813A2/pt not_active IP Right Cessation
- 2013-05-21 CA CA2872179A patent/CA2872179A1/en not_active Abandoned
- 2013-05-21 MX MX2014013839A patent/MX2014013839A/es unknown
- 2013-05-21 EP EP13725321.7A patent/EP2855469B1/en active Active
-
2014
- 2014-10-27 CR CR20140495A patent/CR20140495A/es unknown
- 2014-11-11 CO CO14249385A patent/CO7131369A2/es unknown
- 2014-11-13 IL IL235681A patent/IL235681A/en not_active IP Right Cessation
- 2014-11-14 PH PH12014502541A patent/PH12014502541A1/en unknown
- 2014-11-18 CL CL2014003123A patent/CL2014003123A1/es unknown
- 2014-12-24 MA MA37691A patent/MA37691B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201407575PA (en) | 2014-12-30 |
| US9273042B2 (en) | 2016-03-01 |
| PE20150021A1 (es) | 2015-01-28 |
| EA201492097A1 (ru) | 2015-04-30 |
| MA37691B1 (fr) | 2016-11-30 |
| MA37691A1 (fr) | 2016-03-31 |
| US20150141413A1 (en) | 2015-05-21 |
| NZ702254A (en) | 2016-08-26 |
| JP2015517548A (ja) | 2015-06-22 |
| CA2872179A1 (en) | 2013-11-28 |
| EP2855469B1 (en) | 2019-06-19 |
| KR20150014934A (ko) | 2015-02-09 |
| IL235681A0 (en) | 2015-02-01 |
| PH12014502541B1 (en) | 2015-01-21 |
| CN104334554B (zh) | 2017-10-31 |
| AU2013265376B2 (en) | 2017-07-20 |
| IL235681A (en) | 2017-10-31 |
| EA026004B1 (ru) | 2017-02-28 |
| PH12014502541A1 (en) | 2015-01-21 |
| WO2013174781A1 (en) | 2013-11-28 |
| MX2014013839A (es) | 2015-02-04 |
| CN104334554A (zh) | 2015-02-04 |
| CL2014003123A1 (es) | 2015-02-27 |
| HK1201261A1 (en) | 2015-08-28 |
| AU2013265376A1 (en) | 2014-11-13 |
| UA113438C2 (xx) | 2017-01-25 |
| CO7131369A2 (es) | 2014-12-01 |
| JP6251249B2 (ja) | 2017-12-20 |
| EP2855469A1 (en) | 2015-04-08 |
| BR112014028813A2 (pt) | 2017-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| CR20140306A (es) | Fluormetil -5,6-dihidro-4h-[1,3] oxazinas | |
| CR20140495A (es) | 5-amino[1,4]thiazines como inhibidores de bace1 | |
| UY34156A (es) | Compuestos inhibidores de metaloenzimas | |
| IN2015DN00598A (es) | ||
| UY34523A (es) | Derivados de betulina | |
| UY34445A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a | |
| PH12015500263A1 (en) | New bicyclic derivatives | |
| CR20140535A (es) | Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa | |
| UY34092A (es) | Nuevos compuestos como inhibidores de jak | |
| UY34145A (es) | Compuestos inhibidores de metaloenzimas | |
| UA110338C2 (xx) | Хімічні сполуки | |
| EA201590321A1 (ru) | Дейтерированный барицитиниб | |
| UY34146A (es) | Compuestos inhibidores de metaloenzimas | |
| CR20140510A (es) | Nucleósidos de espirooxetano de uracilo | |
| UY34472A (es) | Derivados modificados de 4-fenil-piridina | |
| UY34602A (es) | ?Derivados de bencimidazolil- e imidazopiridinil-metilamina? | |
| IN2014DN09346A (es) | ||
| MX341456B (es) | Amino-quinolinas como inhibidores de cinasa. | |
| CR20130539A (es) | Triazolopiridinas | |
| MX2014014531A (es) | Derivados de aminoquinazolina y piridopirimidina. | |
| EA201591634A1 (ru) | Дигидропиридопиримидиновые соединения | |
| CR20130419A (es) | Derivados heterocíclicos de amina | |
| CR20150271A (es) | Peptidos como agonistas de oxitocina | |
| CR20150084A (es) | 2-oxo-2,3-dihidro-indoles |